AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 41(4), 1989, pp. 436-444
Copyright © 1989 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stephenson, L. S.
Right arrow Articles by Kyobe, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stephenson, L. S.
Right arrow Articles by Kyobe, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*TRICHLORFON

Single does Metrifonate or Praziquantel Treatment in Kenyan Children.

I. Effects on Schistosoma Haematobium, Hookworm, Hemoglobin Levels, Splenomegaly, and Hepatomegaly

Lani S. Stephenson, Stephen N. Kinoti, Michael C. Latham, Kathleen M. Kurz AND John Kyobe
Division of Nutritional Sciences, Cornell University, Ithaca, New York, Medical Research Center, Kenya Medical Research Institute, Nairobi, Kenya; and University of Nairobi, Nairobi, Kenya

The relationships between S. haematobium, hookworm, malaria, hemoglobin level, splenomegaly, and hepatomegaly before and 8 months after treatment with a single dose of metrifonate or praziquantel were studied in Kenyan primary schoolchildren in an area where anemia, S. haematobium, and hookworm are common and malaria is holoendemic. Children with light to moderate S. haematobium infection were examined (Exam 1), assigned at random to groups receiving placebo (PL, n = 104), metrifonate (MT, n = 103, dose 10 mg/kg body weight) or praziquantel (PR, n = 105, dose 40 mg/kg body weight), treated, and examined 8 months later (Exam 2). At Exam 2, 62% of the MT group still passed S. haematobium eggs vs. 13% in the PR group. Egg reduction rates were substantial in both groups, but greater in the PR group; geometric mean egg counts in both groups were very low. Prevalence and intensity in the PL group had not changed between exams. Hookworm egg counts were significantly reduced in the MT group (59% egg reduction rate); malarial infection had increased in all 3 groups, presumably due to the long rainy season between exams. Hookworm egg count was the most significant predictor of initial hemoglobin level, followed by S. haematobium egg count and presence of malarial infection. Treatment with a single dose of MT or PR can produce substantial decreases in S. haematobium infection 8 months later.




This article has been cited by other articles:


Home page
JAMAHome page
M. Reddy, S. S. Gill, S. R. Kalkar, W. Wu, P. J. Anderson, and P. A. Rochon
Oral Drug Therapy for Multiple Neglected Tropical Diseases: A Systematic Review
JAMA, October 24, 2007; 298(16): 1911 - 1924.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
K. Tolentino and J. F. Friedman
An Update on Anemia in Less Developed Countries
Am J Trop Med Hyg, July 1, 2007; 77(1): 44 - 51.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Society of Tropical Medicine and Hygiene.